Cargando…
CML Developing Three Years after Therapy Completion in a Child with Ph(−) Pre-B-ALL
We report a girl with a history of Ph(−) pre-B-ALL and three years of disease-free survival admitting to our hospital for regular end of treatment checkup with an increased white blood cell count which in follow-up studies and molecular detection of BCR-ABL (p210) fusions gene had been diagnosed as...
Autores principales: | Hosseini, S., Bahoush, G. H., Vousogh, P., Ansari, Sh., Arjmandi, Kh., Sabzechian, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420383/ https://www.ncbi.nlm.nih.gov/pubmed/22937310 http://dx.doi.org/10.1155/2011/670603 |
Ejemplares similares
-
Resistant mutations in CML and Ph(+)ALL – role of ponatinib
por: Miller, Geoffrey D, et al.
Publicado: (2014) -
A Fetal Hemolytic Anemia in a Child with Cytomegalovirus Infection
por: Hosseeini, S, et al.
Publicado: (2014) -
Bilateral Maxillary, Sphenoid Sinuses and Lumbosacral Spinal Cord Extramedullary Relapse of CML Following Allogeneic Stem Cell Transplant
por: Hosseini, Soudabeh, et al.
Publicado: (2016) -
Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
por: Bardy-Bouxin, Nathalie, et al.
Publicado: (2015) -
Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)